HOME >> MEDICINE >> NEWS
Vaccine may complement conventional treatment for chronic leukaemia

A vaccine that boosts the immune response could improve the effect of conventional treatment for patients with chronic myeloid leukaemia (CML), suggest early results of a trial published in this week's issue of THE LANCET.

CML is caused by the breakage and swapping of chromosomes 9 and 22, which results in a shortened chromosome called the Philadelphia chromosome. Cells with the abnormal chromosome make a protein that encourages aberrant growth and division. Patients with CML can be treated with a drug called imatinib or interferon alfa. Treatment with imatinib can lead to complete cytogenetic remission, where no Philadelphia chromosomes are detected during cell division. However, a complete molecular response, where there is no evidence of the protein produced by the Philadelphia chromosomes, is rare.

Monica Bocchia (University of Siena, Italy) and colleagues tested whether a vaccine that targets a protein derived from the Philadelphia chromosome could help to eradicate the disease in patients. The investigators enrolled 16 individuals (10 patients on imatinib and 6 on interferon) with stable, but detectable disease into the trial. Patients were given one dose (six injections) of the protein vaccine every 2 weeks while they continued their conventional treatment. Patients were assessed before vaccination and after three and six doses for evidence of the disease.

Nine patients on imatinib showed progressive reduction of their residual disease after three and six doses of the vaccine with five patients reaching complete cytogenetic remission. Three of the five patients also obtained undetectable disease at a molecular level. Of the six patients on interferon alfa, five showed a reduction of their stable disease during vaccinations, with two reaching complete cytogenetic remission.

Dr Bocchia comments: "Our preliminary data suggest that the addition of this vaccine to patients treated with conventional treatment might favour further
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
17-Feb-2005


Page: 1 2

Related medicine news :

1. Vaccine against childhood pneumonia shows promise
2. Vaccine preparedness, or not
3. Oct. 14 Web cast: Reporters Workshop -- Covering Vaccines & Immunizations
4. Vaccine reduces racial disparity in incidence of childhood pneumonia and meningitis
5. Vaccine nips breast cancer in the bud
6. Vaccine shows promise for kidney cancer
7. Vaccine development against influenza A (h5n1) virus should be made a priority
8. Vaccines against fatal African cattle fever
9. Vaccine development sparks debate on changes to cervical cancer screening guidelines
10. Vaccine shortage study exposes nations patchwork system
11. Vaccines prevent cancers of the liver and cervix

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... PITTSBURGH (PRWEB) , ... August 31, 2020 , ... ... Allegheny Health Network (AHN), are joining biomedical engineers from Carnegie Mellon University (CMU) ... alternative for cardiac patients who have undergone open heart surgery. , The AGH/CMU ...
(Date:8/31/2020)... , ... August 31, 2020 , ... ... donated 1,400 N95 face masks to medical first responders across the United States. ... make donations of personal protective equipment (PPE) medical centers , hospitals ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... of innovative higher-learning opportunities through high-quality, career-relevant, and affordable online education – is ... Psychology . , Among the first of its kind in the nation, ...
(Date:8/31/2020)... , ... August 31, 2020 , ... A Cure for Covid-19 “PTS” with Mediation & ... the planet are in a state of panic, experiencing deep anxiety, immense stress, and right ... a solution is timely when most people on the planet are experiencing a great degree ...
(Date:8/31/2020)... ... August 31, 2020 , ... Bonde ... for patients with advanced heart failure, today announced that the company has been ... of $555,358 from the National Heart, Lung, and Blood Institute of the National ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... September 03, 2020 , ... Sickle Cell Disease ... by holding a series of events and supporting the events of member organizations. ... the need for research and treatment of sickle cell disease. , “Individuals and ...
(Date:9/3/2020)... , ... September 03, 2020 , ... ... Boulder’s Vance Lab ( https://www.colorado.edu/lab/vance/masks ), an aerosol and engineering lab, conducted tests ... better protection against the COVID-19 virus than many other masks. Q&J face masks ...
(Date:9/3/2020)... ... September 03, 2020 , ... Using Analysis of Variance ... Thursday, Sept. 17, 2020, 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/anova , How much ... , While one can’t become one in 90 minutes, one can master a ...
Breaking Medicine Technology:
Cached News: